Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trialBrad H. Rovin, Catarina Almeida, Se Won Oh et al.|The Lancet|2023Cited by 264
The copy number variation landscape of congenital anomalies of the kidney and urinary tractMiguel Verbitsky, Robert Pawluch, Rik Westland et al.|Nature Genetics|2018Cited by 240
Genetic Drivers of Kidney Defects in the DiGeorge SyndromeEsther López-Rivera, Maria Szczepańska, Yangfan P. Liu et al.|New England Journal of Medicine|2017Cited by 154
Exome-wide Association Study Identifies GREB1L Mutations in Congenital Kidney MalformationsSimone Sanna‐Cherchi, Ali G. Gharavi, Kamal Khan et al.|The American Journal of Human Genetics|2017Cited by 106
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell CarcinomaFrancesco Lasorsa, Giuseppe Lucarelli, Monica Rutigliano et al.|International Journal of Molecular Sciences|2023Cited by 98